ASTRAZENECA PLC AZN

Andy Barnett — Head of Investor Relations

Pascal Soriot — Chief Executive Officer

Aradhana Sarin — Executive (Finance)

David Fredrickson — Executive (Oncology)

Susan Galbraith — Executive (R&D/Clinical Development)

Ruud Dobber — Executive (Biopharmaceuticals)

Mene Pangalos — Executive (Biopharmaceuticals) / Leadership

Marc Dunoyer — Executive (Rare Disease/Finance)

+4.7%1d on move date+3.7% vs SPY3d+4.9%5d+2.2%

Research tier

Behavioral profile computed for 8 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AZN calls or request research access.

More AZN calls Browse calls Request research access